Schwab U.S. Dividend Equity ETF (SCHD) ETF Price, Holdings & Analysis

What SCHD does

Schwab U.S. Dividend Equity ETF (SCHD) is an exchange-traded fund listed on NYSE Arca that aims to track a dividend-focused index of large-cap U.S. stocks. It belongs to the Dividend category and is part of the Schwab ETFs family. The fund selects companies with a history of paying consistent dividends, and its top holdings include Merck & Co Inc, Abbott Laboratories, Amgen Inc, Coca-Cola Co, and Verizon Communications Inc. Its sector mix leans toward healthcare (21%), consumer defensive (19%), energy (15%), and technology (13%), which gives it a blend of stability and moderate growth exposure.

Key numbers explained

• Price: 33.28 USD — the most recent market price per share.
• Price change today: -0.58% — the daily percentage move, showing a slight decline.
• Trailing P/E ratio: 18.4 — the P/E ratio is calculated by dividing the current share price by the company's trailing twelve-month earnings per share; a lower number can suggest the fund is priced more conservatively relative to earnings.
• Dividend yield: 0% — the dividend yield is the annual dividend payment divided by the share price; this figure reflects the fund's current reported yield.
• 52-week range: 26.32 – 35.31 — the lowest and highest prices over the past year, showing the trading range.
• Fund assets: 112.34B USD — the total market value of all holdings in the fund.
• Fund inception: Oct 20, 2011 — the date the fund was launched.

Recent news

Recent headlines cover how much capital is needed to generate $500 per month in dividends from SCHD, the impact of the latest Fed rate hike on SCHD and money market funds, and the potential of building passive income by investing $275 monthly over 20 years. Other stories note that SCHD shed almost $15B in assets and that the fund is trading near its all-time high, prompting discussion about whether it remains a reasonable entry point.

What to watch

Investors typically monitor dividend policy changes at major holdings such as Merck & Co Inc, Abbott Laboratories, Amgen Inc, Coca-Cola Co, and Verizon Communications Inc. Sector rotation between healthcare, consumer defensive, energy, and technology can shift the fund's risk and income profile. Broad interest-rate moves, as discussed in coverage of the Fed's latest hike and its effect on JEPI and similar instruments, also influence dividend-focused strategies. Comparing SCHD with peers like VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (TDIV), Vanguard FTSE All-World High Dividend Yield UCITS ETF (VHYL), iShares STOXX Global Select Dividend 100 UCITS ETF (DE) (ISPA), Vanguard Dividend Appreciation ETF (VIG), and Vanguard High Dividend Yield ETF (VYM) can provide context on yield and quality. For fixed-income complement, iShares Core U.S. Aggregate Bond ETF (AGG) is a common reference point.